►
From YouTube: COVID-19 Presentation - October 19, 2021
Description
No description was provided for this meeting.
If this is YOUR meeting, an easy way to fix this is to add a description to your video, wherever mtngs.io found it (probably YouTube).
A
Yes,
we
are
think.
Thank
you,
mr
chair
joining
us
up
today
is
dr
miller.
Who's
already
been
here
today
and
dr
varghese.
We
have
a
series
of
about,
I
think
it's
about
11
or
12,
slides
to
walk
through
reuben
is
going
to
give
an
update.
There
has
been
a
lot
going
on
in
the
area
of
vaccines
and
thought
it
was
appropriate
to
check
in
with
the
board
in
the
community
and
give
an
update.
So
once
reuben
gets
settled
in
and
kendra
you
got
the.
I
think
you
have
the
slides
over
to
you.
A
C
C
C
We
are
still
in
the
second
highest
category
of
community
transmission,
which
the
cdc
refers
to
as
substantial
we've
been
fluctuating
between
substantial
and
high,
which
is
the
highest
category
of
community
transmission
by
cdc's
classification.
At
this
point-
and
that's
not
only
true
for
us
but
for
the
region-
and
my
second
comment-
we
know
that
this
is
an
underrepresentation
of
the
number
of
cases
present.
C
We
know
that
people
are
either
not
getting
tested
because
if
they're
symptomatic,
they
may
just
assume
it's
coveted
and
don't
go
for
testing,
hopefully
they're
staying
at
home,
and
there
are
those
taking
it
at
home
tests
which
are
not
necessarily
reported
to
us.
So
if
we're
at
substantial
officially
on
the
chart,
I
wouldn't
be
surprised
that
we're
actually
still
in
substantial
community
transmission.
C
So
this
is
from
the
website.
This
is
a
snapshot
of
the
summary
of
kova
data
since
march
2020,
but
I
think
just
hearing
the
numbers
we
have
had
18
354
cases
which,
as
I
said,
is
an
under
count.
We
have
had
918
people,
hospitalized
and
269
people
who
have
died
and
on
the
latter,
that
is
269
preventable
deaths
too
many
next
slide.
C
C
C
Two
one
three,
if
not
much
lower
than
that,
so
this
is
another
way
of
representing
representing
that
averages-
can
mass
disparities
some
in
our
jurisdiction
have
experienced
greater
exposure
risk
than
others
slide
five
next,
this
depicts
the
cases
and
deaths
by
age
group
in
the
top
slide,
with
case
rate
you'll,
see
in
the
dotted
line,
the
all
age
rate
case
and
three
groups,
those
between
20
and
59,
and
those
80
and
older
experience.
C
These
two
groups
experienced
higher
exposure
rates
and
the
latter
group
experienced
the
highest
rate
of
complications
due
to
covet
the
ultimate
complication
being
death
so
and
in
the
second
graph,
you
can
see
the
rise
in
case
rate
as
we
increase
in
age
by
cohort.
So
obviously,
aging
is
another
unfortunate
risk
factor
that
we
see
not
only
with
covet
but
with
other
infectious
diseases.
C
This
data
shows
population,
cova,
19
case
population
and
covet
19,
vaccinated
vaccine
population
by
race
and
ethnicity,
just
to
point
out,
while
almost
16
percent
of
our
residents
report
being
hispanic,
they
represent
over
25
percent
of
cover
19
cases
and
only
16
of
those
with
at
least
one
dose
of
vaccine.
That's
roughly
the
percentage
of
the
community,
but
obviously
we
don't
know
who's
among
the
unvaccinated.
C
What
that
percentage
is,
I
hope,
it's
representative,
but
it's
still
one
a
conclusion
that
we
can't
officially
make
and
then
over
sixty
percent
of
residents
identify
as
non-hispanic
white,
yet
they
represent
forty
percent
of
cover
nineteen
cases
and
represent
fifty
percent
of
those
vaccinated
to
date.
I
would
say
that
some
of
the
upstream
inequities
in
our
societal
systems
may
play
a
role
in
these
downstream
disparities.
We
are
witness
to
next
slide.
C
This
slide
depicts
the
vaccination
rates
by
age
group
for
those
eligible
for
vaccine
and
binder
at
present.
Everyone
12
and
older
is
eligible,
and
among
that
so
the
total
is
78.8
percent
of
those
eligible
to
receive
vaccine
have
received
at
least
one
dose
of
vaccine.
So
that's
good
and
the
reason
why
I
say
that
is
for
two
reasons:
it's
a
fantastic
number
compared
to
most
places,
and
we
know
there
are
doses
of
our
residents.
C
And
then,
if
you
look
at
the
next
two
groups,
40
49
and
50
to
59,
that's
over
10
000
individuals
so
of
the
45
000
people
roughly
unvaccinated
in
arlington,
who
are
eligible.
35
000
fall
in
those
age
groups,
so
we've
done
well
and
it
would
be
fantastic
if
those
with
influence
can
encourage
them
to
go
move
in
that
direction.
C
So
I
wanted
to
just
the
reason
why
you
of
the
slide
from
last
year,
which
I
did
show
you,
is
to
emphasize
that
exposure,
risk
and
complication
risks
are
different
risks
and
those
things
still
matter.
Even
though
we
have
vaccine
because
vaccine
didn't
change,
why
people
are
at
risk
or
why
people
are
complication
risk,
and
I
think
sometimes
everyone
looks
at
vaccine
as
the
saving
grace
and
it's
a
fantastic
thing,
but
I
don't
want
loose.
Have
people
lose
sight?
What
put
people
at
risk
to
begin
with
in
some
ways
and
so
the
risk
of
exposure?
C
I'm
not
going
to
read
all
of
that,
but
it
summarizes
to
the
risk
of
exposure
increases
as
you're
unable
to
stay
at
home
and
as
you're
unable
to
maintain
six
foot
distances
before
to
perform
your
activities
of
daily
living
or
your
work.
So
that's
true
for
both
vaccinated
and
unvaccinated
individuals.
C
C
It's
just
that
if
you
are
a
vaccinated
individual
and
get
exposed,
the
likelihood
of
having
complications
is
going
to
be
significantly
less
than
those
who
are
unvaccinated
and
the
risk
for
cobin
19
complications
increases
as
your
immune
system
becomes
more
compromised,
including
having
chronic
medical
conditions
and
or
as
you
age
and,
of
course,
having
the
two
together
amplifies
that
complication
risk,
and
so
with
the
kernels
colin
powell's
recent
deaths
reminder
apparently
in
the
news
he
had
multiple
myeloma,
it's
a
type
of
bone
marrow
cancer,
and
now
you
have
indiv
so
he's
immunocompromised,
but
he's
vaccinated,
but
also
being
in
his
80s.
C
That's
another
complication
that,
if
you
get
ill
it'll
be
harder
to
fight
it.
So
it's
just
to
remind
people
that
the
risk
of
exposures
and
complications
may
be
disparately
experienced
in
our
communities,
and
sometimes
it's
because
of
how
society
organizes
itself.
Some
people
say.
Are
you
saying
age
is
the
risk
factor,
not
necessarily,
but
if
we
don't
have
the
right
controls
to
say,
infection
control
is
even
more
important
in
congregate
care
facilities.
C
Well
then,
they
may
not
have
the
resources
or
the
desire
to
put
in
more
stringent
infection
control
measures
to
protect
everyone.
So
those
are
some
of
the
things
I'm
using
the
opportunity
just
to
remind
everyone.
Whoever
is
influential
in
our
community
to
remind
people.
There
are
things
that
we
can
still
do.
D
Sure,
just
a
brief
update,
because
I
like
to
keep
you
apprised
of
where
we
are
with
testing
within
the
community.
To
date,
arlington
county
has
seen
about
367
000
pcr
tests
conducted
and
reported
to
the
virginia
department
of
health
about
64
000
of
those
have
come
from
arlington
county
provided
sites
still
around
the
20
mark
that
we
have
hovered
at
for
the
majority
of
the
pandemic.
The
three
sites
that
we
have
remain
virginia
highlands
park,
courthouse
plaza
arlington
mill.
They
are
open,
11
to
7
every
day,
no
appointment
necessary,
no
insurance
is
required.
D
No
doctor's
referral
is
required
if
individuals
would
like
to
make
an
appointment.
The
last
appointment
is
accepted
at
6
30,
so
it
leaves
time
obviously,
to
collect
and
and
and
process
the
individuals
through
easy
readily
available.
D
No
no
age
requirement.
I
cannot
speak
highly
enough
of
them.
I
have
used
them
on
more
than
at
this
point,
I
would
say
10
occasions,
because,
like
many
individuals
in
the
community,
I
have
a
child
that
is
too
young
to
be
vaccinated
and
with
every
illness
that
comes
with
school,
we
opt
to
take
dr
varghese's
advice
and
make
sure
that
we
are
testing
making
sure
that
we're
protecting
not
only
ourselves
but
members
within
the
community
until
she
is
able
to
get
vaccinated.
D
So
I
highly
encourage
individuals
out
there
if
you
wake
up
with
the
sniffles
it's
new,
even
if
you
are
vaccinated
and
you're
still
just
not
feeling
well
use
those
testing
services,
know
your
status
and
help
protect
you,
your
members
of
family
and
the
community.
C
Thank
you
so
moving
on
to
some
of
the
good
news
on
vaccines,
I
thought
I'd
first
talk
about
the
adults
and
then
have
a
separate
slide
on
children.
So
let
me
review
the
information
you
see
here
so
in
the
top
line,
you'll
see
johnson
johnson
and
it
was
approved
it's
still
under
fda
ewa
for
those
18
and
older,
and
that's
been
since
february.
C
C
The
additional
doses
were
approved
on
in
august
2021
and
the
booster
is
pending
and
just
as
a
reminder,
I
just
realized
to
make
sure
people
understand
additional
versus
booster.
An
additional
dose
is
for
people
who
may
not
have
had
a
strong
enough
immune
response
from
the
primary
series,
and
so
in
the
mr
mrna
case.
That
would
be
two
doses
three
or
four
weeks
apart
and
then
they
based
on
the
studies,
felt
that
there
was
some
degree
of
reduction
in
immunity,
and
so
it's
not
like
it
falls
off
a
cliff.
C
You
have
time
to
go,
get
your
booster
and
then
pfizer
has
had
the
approved
for
use
for
18.
I
should
have
corrected
that
all
of
those
are
approved
as
they
are
listed
there,
but
actually
for
additional
doses.
It's
only
for
or
it's
actually
it
should
only
be
for
18
and
older
so
and
the
same
for
boosters,
my
apologies.
C
We
will
correct
that,
and
as
soon
as
modern
and
j
and
j
are
available,
our
clinics
at
walter,
reed
and
arlington
mill
will
be
able
to
accommodate
and
then
we'll
be
doing
all
three
at
those
sites
they're
currently
being
done
by
appointment,
and
they
should
also
be
available
at
the
area,
pharmacies
and
we
have
still
believe
over
30
places
in
arlington
and
in
26
square
mile
jurisdiction.
So
there
are
multiple
options
for
our
residents
either.
C
right
now.
Nothing
has
been
submitted
for
johnson
and
johnson
moderna.
As
we've
said,
the
12
to
17
category
has
been
submitted.
It
was
submitted
back
in
june
and
we
know
that
the
fda
at
some
point
asked
for
additional
data.
So
that's
why
we
suspect
it's
pending
we're
anticipating,
if
you
believe
all
the
reports
in
the
press,
six
to
11
would
be
sometime.
This
fall,
but
once
again
there
have
been
nothing
scheduled
so
right
now,
once
again,
I
say
under
six
would
be
speculation,
so
the
entire
focus
is
on
pfizer.
C
C
The
5
to
11
the
fda
advisory
panel
meeting
is
scheduled
for
october
26,
which
is
next
week,
so
assuming
that
goes
well,
and
they
actually
approve
that,
then
it
would
or
recommend
it.
It
would
then
go
to
the
fda,
commissioner,
for
their
decision.
Typically,
the
acip
meeting,
which
I
believe
has
been
scheduled
will
be
a
few
days
later
and
they
will
then
consider
which
age
groups
and
so
on.
They
would
officially
recommend
for
doctors
to
actually
prescribe.
C
C
C
It
doesn't
mean
that
the
us
hasn't
actually
purchased
enough
vaccine
for
all
children,
but
just
because
it's
been
purchased,
it
has
to
actually
be
produced
and
be
in
cdc's
hands
so
and
at
present,
without
hearing
what
go
the
deliberations
at
the
meeting,
there
is
no
proposal
for
using
or
adjusting
the
adult
dose
to
make
it
appropriate
for
children,
so
the
return
of
per
capita
allocation
is
entirely
possible.
C
I
think
likely
the
state
will
modify
it
slightly
for
the
actual
uptake
that's
been
seen
between
for
12
to
19
year
olds
in
each
community,
but
that
doesn't
mean
first
of
all,
if
there's
a
limited
supply
of
it's
per
capita,
there's
only
going
to
be
so
much
coming
to
each
state,
which
then
gets
divided,
and
so
it
will
likely
take
a
little
bit
longer
than
people
had
wanted.
So
we're
waiting
for
all
the
teas
to
be
crossed
eyes
dotted
before
we
make
any
public
proclamations.
C
Having
said
that,
we
are
planning
for
vaccination
clinics
which
will
be
by
appointment,
because
it's
the
only
way
to
assure
the
distances
and
to
do
things
safely.
The
current
plan
is
to
do
something
similar
to
what
we
did
back
at
the
end
of
may
and
through
the
summer
having
weekend
clinics
solely
for
children.
The
difference
is,
we
were
able
to
do
sometimes
three-day
weekend
sort
of
activities
because
school
wasn't
in
session.
C
So
we'll
have
the
capacity,
but
once
again
like
last
year
and
as
dr
miller
would
always
say,
you
know
we
need
to
have
the
vaccine
to
actually
be
able
to
give
it.
So
I
hope
I'm
wrong
in
reading
the
tea
leaves,
but
this
isn't
the
first
time
we've
heard
this
before
so
and
then
whatever
the
initial
uptake
is
we're
going
to
reassess
after
we
have
about
16,
000
kids
who
fit
in
that
category.
Some
at
some
point,
maybe
halfway
through
we'll,
reassess
if
there
seems
to
be
a
slight
drop
off.
C
Do
we
need
to
continue
those
large
clinics,
as
well
as
thinking
about
targeted
neighborhood
events
and
then
ultimately
doing
some
in-school
vaccination,
but
getting
a
prior
parental
consent.
But
of
course
that's
a
bit
more
complicated
process,
but
then
we
would
use
our
school
health
nurses,
supplemented
by
division
staff
to
help
do
it
in
the
schools.
But
we
have
to
maintain
the
health
care
standards,
not
the
school
standards.
So
we
still
maintain
six
foot
distances.
All
those
schools
are
permitted
to
go
as
low
as
three
foot
distances.
C
C
This
is
the
first
okay,
vaccines
for
children,
greater
than
five
and
under
12
should
be
coming
with
the
caveats.
I've
talked
about
vaccines
for
those
between
two
and
five.
The
earliest
I
can
imagine,
is
sometime
the
beginning
of
next
year,
springtime
and
beyond
that.
I'm
not
even
gonna
try
to
speculate
so
we
continue
to
recommend
those
who
are
immunocompromised
to
get
the
additional
doses
for
those
that
are
approved
and
boosters
for
waning
immunity
for
pfizer
and
then
soon
for
the
moderna
and
jnj.
C
C
If
we
want
to
reduce
the
risk
to
certain
groups
already
mentioned
and
the
takeaway
what
people
can
still
do
will
be
this
and
a
visual
continue
with
the
layered
strategies
or
the
swiss
cheese
model
to
reduce
risk
of
continued
exposure
to
coven
as
no
vaccine
is
100
percent.
It
helps
you,
your
loved
ones
and
our
community,
and
so
next
slide
final
one.
This
is
that
swiss
cheese
slide
that
staff
modified
from
a
virologist
named
ian
mckay
and
no
single
strategy
or
swiss
cheese
layer
is
perfect
at
preventing
the
spread
of
kova
19.
C
Each
strategy
has
weaknesses
or
holes,
use
multiple
overlapping
layers
to
block
more
holes,
and
it
reduces
how
much
cobit
19
may
get
through
this
graphic
and
a
one-page
handout
is
on
the
website
and
is
in
english,
spanish
and
at
least
four
to
six
other
languages.
So
we
encourage
people
listening
to
print
it
out
post
up
all
over
the
place,
because
this
is
really
what's
important
to
protect
our
community
as
an
individual.
If
you're
leading
an
organization
and
my
recommendation
to
populations,
and
with
that,
I
will
stop.
B
Thank
you,
dr
varghese.
We
there's
a
lot
of
new
information.
It's
a
we
haven't
had
we
haven't,
we've
been
in
sort
of
a
steady
work
against
the
virus
over
the
past
two
months,
so
it's
great
to
get
an
update
and-
and
I
suspect
those
those
slides
might
be
just
time
sensitive
as
to
when
they
when
they
apply,
but
I
think
we
probably
all
would
love
to
take
a
look
at
them.
B
If
we
can,
if
we
can,
I
don't
know
if
there
are
questions
I
just
have
one
and
it's
regarding
five
to
eleven
year
olds.
I
think
the
whole
community
is
waiting
for
that
is
excited
for
that.
So
would
the
weekends
would
it
be
walter,
reed
and
arlington
mill?
That
would
continue
to
be
the
sites
for
those
weekends.
We
wouldn't
be
going
to
larger
sites.
Just
those
two
right
well
at
that.
C
Point
it
would
be
those
two
sites,
the
setup
and
breakdown
of
other
sites.
Typically,
schools
would
just
be
really
quite
difficult,
so
we're
not.
We
wouldn't
have
on
those
weekends,
any
adult
activities
it
would
be
strictly
for
children,
and
so
part
of
is
related
to
the
number
of
doses
available
as
well.
C
They
can
take
children
out
of
school
during
the
day.
We're
going
to
try
to
we'll
have
all
of
our
daytime
clinics
go
all
the
way
till
seven,
and
so
we're
going
to
allocate
slots
just
for
kids
as
well.
Once
we
have
a
better
sense
of
how
much
we
have
in
hand
so
that
we'll
have
the
weekend
clinics
devoted
just
to
kids
to
get
the
largest
volume
out
with
the
available
vaccine
and
then
whatever
remaining
doses
we
distribute
during
the
week
and
then
as
supply
increases,
we'll
also
release
it
to
pharmacies
and
other
providers.
C
The
thing
that
I
have
to
remind
people
is
it's
open
to
all
kids
from
anywhere
that's
going
to
be
the
case
for
all
of
virginia
and
the
whole
region
since
its
federal
vaccine.
We
can't
limit
it
to.
Nor
should
we
limit
it
to
just
arlington.
E
C
Absolutely
we
should
absolutely
encourage
people
to
get
the
flu
shot.
Adults,
especially
you
can
get
the
covet
vaccine
and
the
flu
vaccine.
At
the
same
time,
there
is
no
prohibition
against
that.
So,
if
you
haven't
received
your
flu
shot
or
your
kovacho,
please
go
get
both
of
them.
We
will
not
be
providing
flu
shots
at
these
clinics
because
it's
going
to
be
tough
enough
to
probably
deal
with
children
and
some
of
their
own
concerns
with
one
shot,
let
alone
two.
But
there
are
many
more
opportunities
out
there.
E
Yep
great
so
get
your
flu
shot.
I
had
one
other
question
if
I
might
and
that
I
realized,
whenever
we
have
information
about
the
number
of
people
who
are
vaccinated
fully
vaccinated
partially,
how
many
people
do
we
think
I've
just
gotten
one
shot
and
they're
not
going
to
get
fully
vaccinated?
Is
there
some
information
on
that
because
I'm
guessing
there's,
maybe
a
good
chunk
of
the
population
that
just
like
there's
so
that
will
never
get
a
vaccination,
there's,
probably
a
chunk
that
maybe
will
never
go
for
that.
Second.
C
We
haven't
seen
too
many
without
that
have
gone
well
beyond
42
days
without
getting
their
second
shot.
There
are
some
and
we
try
to
do
follow-up
to
remind
them
and
encourage
them
to
get
that.
It
actually
has
not
been
as
much
of
a
problem
here
in
arlington,
as
perhaps
other
places
there
will
be
some
that
have
forgotten
to
come
back,
and
so
we
have
tried
sending
out
reminders,
but.
G
Thank
you,
mr
chair,
and
thank
you
for
the
presentation,
the
update
and
I
couldn't
be
more
thankful
for
the
very
efficient
way,
dr
miller,
that
the
testing
works.
I
use
it
myself
every
week,
10
days
more
or
less,
I
see
a
lot
of
people,
so
I
think,
for
the
same
reasons
that
you
are
taking
the
test,
I'm
taking
the
test
too,
and
so
we
recommend
for
everybody.
I
had
a
a
question
about
the
the
logistics
for
the
five
to
11
year
olds.
G
So
correctly
you
pointed
out
that
we
will
will
be
running
a
appointment
system
for
that.
So
what
is
the
early
information
that
we
can
give?
Where
should
how
how
when,
when
we
get
approval,
what
happens
next?
How
do
we
let
everybody
know
that
you
know
their
their
kids
are
now
eligible,
and
how
do
we
instruct
them
to
to
make
an
appointment.
C
Sure
excellent
question,
so
part
of
the
the
issue
is
even
with
the
approvals
the
timing
of
these
things
becomes
very
critical
in
the
decision-making
process
as
well.
If
all
goes
well,
it's
entirely
possible
that
cdc
will
be
issuing
their
approval
on
a
friday
evening.
Does
not
it's
been
the
case
for
some
reason
for
all
of
these,
I
sometimes
wish
they
would
do
better
in
their
planning,
but
there
you
go
and
then
the
virginia
has
to
then
issue
its
approval
before
we
can
even
contemplate
opening
up
officially
things,
because
you
have
to
weigh
the
balance.
C
I
know
briana
helfer
and
the
cape
team
are
stand
ready
to
work
with
the
school
system
to
put
out
messaging
through
the
school
system,
as
well
as
through
our
regular
channels
to
let
people
know
how
they
can
go
about
doing
this,
but
it
will
be
a
computer-based
system
for
the
majority,
but
I
know
that
the
dhs
staff
under
anita
are
prepared
to
also
help
make
appointments
for
those
who
haven't
come
up
with
that.
C
We
haven't
worked
through
any
of
those
details
yet,
but
that's
partly
because
we
need
to
be
able
to
let
people
know
what
to
be
told,
which
is
unfortunately
one
of
the
other
things
we
don't
know
yet
what
the
caveats
may
be
for
the
vaccination
as
well.
That's
so
we've
got
a
infrastructure,
that's
possible,
but
we
don't
know
which
one
to
release,
because
there's
no
model
in
one
sense,
mr
carantonis.
We
have
to
build
it
as
we're
flying
it,
but
we're
trying
to
build
it
on
what
we've
already
known.
C
G
C
G
And
and
just
to
follow
up
on
on
boosters,
so
I
I've
seen
the
slide,
so
we
are
waiting
for
some
to
be
at
all
approved,
and
so
the
the
population
of
the
population
that's
first
eligible
for
them
are
pop,
is
a
population
that
is
either
immunocompromised
or
some
somewhat
you
know
has,
has
a
more
you
know:
weak
a
weaker,
weaker
immune
response,
so
we
are
inviting.
C
We
don't
know
any
of
those
individuals
that
is
the
beauty
of
our
lack
of
national
health
care
system.
Had
we
known
that
those
would
probably
have
been
sent
out
to
people,
so
we
take
people's
word
that
they
know
their
immunocompromised
status,
so
they're
already
eligible,
and
they
already
can
get
the
vaccine
and
a
number
of
those
individuals
know
who
they
are.
It's
because
the
group
that
they're
talking
about
are
people
like
organ
transplant
individuals,
so
they're,
usually
within
care,
continuing
to
receive
that
level
of
care.
C
So
those
individuals
it
would
be
surprising
to
not
have
their
systems
letting
them
know
you
should
go,
get
that
they're
usually
instructed
in
many
ways
as
part
of
their
care,
to
always
pay
attention
to
those
things.
Having
said
that,
it's
also
self
attestation
for
immunocompromised
states.
So
we
are
trusting
people
when
they
come
if
they
say
we're
here
list
all
the
reasons
for
those
who
can
get
the
pfizer
booster
at
the
moment
and
if
they
say
yes,
we
give
them
that
shot
or
in
the
at
the
pharmacies
in
the
community
or
doctor's
offices.
C
So
the
immunocompromised
in
theory
have
been
identified
where
the
holes
will
be,
of
course,
of
those
who
are
not
in
healthcare
in
general.
But
that
was
the
issue
prior
to
this.
To
begin
with,
and
as
I
said
before,
there's
little
that
public
health
can
do
unless
the
larger
society
starts
saying
we
need
a
different
system,
we'll
keep
putting
those
messages
out
and
if
they
really
feel
that
they're
in
that
category,
no
one's
going
to
police
them
in
and
deny
them
access
to
the
vaccine.
C
If
they're,
looking,
though,
for
a
booster,
rather
than
an
additional
dose,
we're
close
with
modern
and
j
and
j,
so
I'm
hoping
those
who
are
hearing
who
may
not
have
access
realize
that
they
have
access
to
the
arlington
free
clinic
and
neighborhood
health
to
develop
a
medical
home
and
a
relationship
where
they
can
get
those
sorts
of
questions
answered
about
their
health
care,
and
should
they
or
should
they
not
get
those
things.
G
F
C
Not
off
the
top
of
my
head,
but
we
have
had
some
and
we've
seen
an
upticks
are
for
instructing
since
the
mandates
have
occurred.
It
is
one
of
the
ways
that
some
people
have
gotten
into
compliance
with
being
one
one
and
done
we've
seen
it
increase
in
the
number
of
people
coming
and
getting
the
j
and
j
vaccines
at
least
a
public
health
clinic.
F
So
we
always
theorize
that
it
would
be
popular
among
the
vaccine,
hesitant
to
only
do
a
one
shot
regime,
but
given
that
the
the
fda
panel
recently,
you
know
recommended
that
the
full
fda
approve
a
jnj
booster,
I
mean
two
questions
from
that
are
we
do
we
have
enough
supply
if
that
should
come
imminently?
If,
if
your
calendar
is
correct,
consistent
with
past
practice,
panel
approves
within
days
or
a
week,
the
fda
follows
suit.
C
Hopefully
we
can
encourage
people
to
get
the
booster,
but
one
of
the
things
that
I
want
to
remind
people,
the
j
j
data
they
have
been
able
to
stay
at
about
the
70
mark
in
efficacy
for
a
much
longer
period
of
time.
It's
just
that
the
medical
advisory
group
felt
that,
given
that
there
was
evidence
that
you
could
boost
that
to
be
higher,
so
in
some
ways
what's
happened
with
the
primary
series
so
mrna,
especially
fish
or
more
than
moderna
they've,
seen
a
more
steady
decline.
It
hasn't
gone
below
70
percent,
but
you
know
it's.
C
F
Thank
you,
and
I
don't
know
if
you
can
miss
jacobs
if
you
can
pull
up
dr
ruggies
presentation
and
the
one
with
the
two
pie
charts
the
demographic
data.
I
just
wanted
to
make
sure
I
was
capturing
and
assimilating
all
that
information.
As
you
said,
it's.
C
All
on
our
website,
but
I
thought
this
time
doing
it
slightly
differently,
would
capture
or
ask
raise
different
questions,
because
we
do
not
present
all
of
this
data
all
on
one
slide,
terrific.
So
so,
if
you
wouldn't
mind
I'll
be
happy
to
go
through
each
one
as
just
as
a
reminder
sure
the
far
to
my
far
left
is
the
actual
population
by
race
and
ethnicity,
the
general
distribution
based
on
census
data.
F
C
You
could
read
it
that
way.
What
I
would
also
say
is
what
we
don't
know
is
how
many
people
are
unvaccinated
in
some
of
the
same
numbers
that
I've
talked
about.
So
therefore,
my
concern
of
any
of
this
data
is
for
the
groups
that
are
unvaccinated.
How
would
that?
What's
the
distribution
there
as
well?
But
yes,
I
think
you
could
say
fewer
white
individuals
have
gotten
the
vaccine
compared
to
their
percentage
in
the
population.
C
That
is
definitely
true,
okay,
but
I
think
what
we,
because
I
don't
know
how
many,
what
the
distribution
of
the
folks
who
are
unvaccinated
if
we
go
on
traditional
fault
lines
for
lack
of
a
better
term,
I'm
sure
there's
a
better
term.
Someone
will
tell
me
if
people
are
hesitant
and
it's
higher
in
minority
and
racial
and
ethnic
groups.
Will
we
see
that
the
group
and
the
unvaccinated
is
that
a
certain
distribution?
C
What
I
don't
have
the
data
for
that
is
what
percentage
of
that
are:
hispanic,
latino,
how
what
percentage
are
african-american?
What
percentage
are
white
in
that
sense,
because
it's
hard
to
go
and
find
those
individuals
to
get
that
information?
If
that
compromise
is,
if
that's
not
based
on
the
same
degree
of
the
race
ethnicity
of
that
last
column,
there,
then
that
could
change
the
conclusions
that
I'd
make
on
the
vaccine.
Thank
you
and.
F
If
I
could
sing
a
third
one
in
mr
chair,
just
you
know
asking
for
a
friend
if
we
take
the
5
to
11
age
group
and
have
a
similar
performance
as
we
did
with
12
to
17,
I
mean
we're
talking
about
15
000
shots
needing
to
go
in
arms
or
reg
series
of
shots
going
into
arms.
How
long
approximately
would
that
take
with
the
levels
of
vaccine?
You
expect
that
we'll
get
given
that
it's
going
to
be
a
new
dosage.
C
C
Okay,
because
if
we
go
on
the
basis
of
what
we
had
previously,
if
they
were
to
give
us
6
000
doses,
I
can
imagine
the
cdc
and
others
recommending
that
you
hold
the
second
dose,
which
you
know
is
controversial,
which
then
means,
if
you
have
six
thousand
dose.
If
you
hold
the
second
dose,
you
can
vaccinate
three
thousand
people
and
then,
if
each
subsequent
week,
let's
say
it's
2
000
doses
coming
same
process,
then
that
would
be
in
a
thousand
saving
a
thousand.
So
until
that
changes
whatever.
C
That
math
is
that
I
just
came
up
with
that
if
it
was
basically
3
000
and
then
whatever
that'll
take
us
some
time.
I
don't
think
it
should
take
that
long.
But
that's
me
hoping
rather
than
knowing-
and
this
is
where
I'd
like
to
hear
a
little
bit
more
granularity
from
someone
much
much
higher
than
the
health
commissioner
of
virginia.
I
mean
we
need
to
know
what
is
known
and
maybe
they're
afraid
to
quite
say
anything
yet,
because
maybe
there
will
be
a
miracle.
But
I'd
like
to
hear
the
specifics
to
know.
C
When
are
we
going
to
be
able
to
get
it
out
as
quickly
as
possible
to
vaccinate,
because
I
think
we
will
have
interest,
but
I
know
there
will
be
some
parents
who
have
been
less
keen
on
this
because
they've
worried
about
long-term
effects-
and
you
know
the
majority
of
our
parents
have
gotten
vaccinated,
but
I
I
can
appreciate
there
are
people
who
are
worried,
so
they
don't
have
to
jump
in
line
first
and
they
can
see
what
happens
with
how
the
rollout
goes
with
everyone
else.
F
C
B
Thank
you
it's
hard
to
forget
when
we
were
low
on
supply
in
january
and
february.
It's
just
I'll,
never
forget
that
period,
but
then
the
work
that
we
did
together
as
we
got
into
march
april
and
may
and
june
there's
progress,
but
we
have
to
continue
to
be
vigilant
and
continue
to
work.
Thank
you,
dr
varghese
and
dr
miller
for
your
presentation
and
your
continued
work.
It
has
been
two
marathons,
not
just
one
that
I
feel
like
we've
been
working
through.
So
thanks
very
much.
I
appreciate
it
with
that
we
will
go.
B
I
will
make
a
motion
that
we
go
into
closed
session,
we'll
be
returning
no
sooner
than
6
30.
But
as
far
as
closed
session,
I
make
the
following
motion.
I
move
the
county
board
convene
a
closed
meeting
is
authorized
by
virginia
code
sections,
2.2-3711,
a1,
3
and
8
for
a
discussion
regarding
the
performance
of
one
board
appointee
and
the
appointment
of
a
board
appointee
and
a
discussion
regarding
candidates
for
appointment
by
the
county
board
and
a
discussion
regarding
the
act.